ALYQ
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 29 Aug 2025)
What this means for you
Registered since 23 Apr 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87676268
- Registration number
- 5734762
- Mark type
- Stylized text
- Filed
- 08 Nov 2017
- Published for opposition
- 04 Sept 2018
- Registered
- 23 Apr 2019
- Attorney of record
- Lori Wolfe
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders
Owner
- Teva Pharmaceuticals USA, Inc., Parsippany, NJ, US
- Teva Pharmaceuticals USA, Inc., North Wales, PA, US
- Teva Pharmaceuticals USA, Inc., North Wales, PA, US
Prosecution history
- 18 Mar 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 18 Mar 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 18 Mar 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 29 Aug 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 29 Aug 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 29 Aug 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 23 Apr 2025 — TEAS SECTION 8 & 15 RECEIVED
- 23 Apr 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 23 Apr 2019 — REGISTERED-PRINCIPAL REGISTER
- 19 Mar 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 18 Mar 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 04 Mar 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 08 Feb 2019 — USE AMENDMENT FILED
- 27 Feb 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 08 Feb 2019 — TEAS STATEMENT OF USE RECEIVED